Quick search
In Drug search, users can search candidate drugs/compounds that associate with CST.
Result
This table shows chemicals/drugs, their mechanism of action(MOA) and association with CST.
| Chemical | Cancer | MOA | Association | ||
|---|---|---|---|---|---|
| ketoconazole | PRAD | Sterol demethylase inhibitor | negatively | ||
| kinetin-riboside | PRAD | Apoptosis stimulant | negatively | ||
| KU-C103885 | PRAD | Cystic fibrosis transmembrane conductance regulator inhibitor | negatively | ||
| L-161982 | PRAD | Prostanoid receptor antagonist | negatively | ||
| LE-300 | PRAD | Dopamine receptor antagonist | negatively | ||
| linifanib | PRAD | PDGFR receptor inhibitor | negatively | ||
| lobeline | PRAD | Acetylcholine receptor antagonist | negatively | ||
| MDL-72832 | PRAD | Serotonin receptor agonist | negatively | ||
| MST-312 | PRAD | Telomerase inhibitor | negatively | ||
| NECA | PRAD | Adenosine receptor agonist | negatively | ||
| niridazole | PRAD | Phosphofructokinase inhibitor | negatively | ||
| nocodazole | PRAD | Tubulin inhibitor | negatively | ||
| NSC-632839 | PRAD | Ubiquitin specific protease inhibitor | negatively | ||
| ochratoxin-a | PRAD | Phenylalanyl tRNA synthetase inhibitor | negatively | ||
| ofloxacin | PRAD | Bacterial DNA gyrase inhibitor | negatively | ||
| ON-01910 | PRAD | PLK inhibitor | negatively | ||
| orantinib | PRAD | FGFR inhibitor | negatively | ||
| oxymetazoline | PRAD | Adrenergic receptor agonist | negatively | ||
| oxymetholone | PRAD | Androgen receptor agonist | negatively | ||
| palonosetron | PRAD | Serotonin receptor antagonist | negatively | ||